- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/12 - Cyclic peptides
Patent holdings for IPC class A61K 38/12
Total number of patents in this class: 2836
10-year publication summary
|
180
|
249
|
259
|
209
|
268
|
242
|
279
|
260
|
191
|
56
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 18943 |
46 |
| Aileron Therapeutics, Inc. | 85 |
40 |
| Bristol-myers Squibb Company | 5080 |
32 |
| Shanghai Techwell Biopharmaceutical Co., Ltd. | 66 |
28 |
| Palatin Technologies, Inc. | 79 |
26 |
| Polyphor AG | 101 |
26 |
| Novartis AG | 11238 |
25 |
| Apellis Pharmaceuticals, Inc. | 109 |
25 |
| Xellia Pharmaceuticals ApS | 114 |
22 |
| Ohio State Innovation Foundation | 1770 |
21 |
| University of South Florida | 1817 |
20 |
| Cidara Therapeutics, Inc. | 87 |
20 |
| Ra Pharmaceuticals, Inc. | 76 |
20 |
| Saint Regis Mohawk Tribe | 34 |
20 |
| Bicyclerd Limited | 130 |
19 |
| Ampio Pharmaceuticals, Inc. | 46 |
18 |
| Helperby Therapeutics Limited | 61 |
18 |
| Centre National de La Recherche Scientifique | 9632 |
17 |
| President and Fellows of Harvard College | 5792 |
17 |
| Rhythm Pharmaceuticals, Inc. | 63 |
17 |
| Other owners | 2359 |